43 results
8-K
EX-99.1
NKTR
Nektar Therapeutics
25 Apr 22
Nektar Therapeutics Announces Strategic Reorganization Plan and Corporate Outlook
4:40pm
will be succeeded by Dr. Brian Kotzin, Nektar’s Head of Immunology, who brings over 30 years of drug development experience to the role and is an expert
424B5
8fwnuyc
23 Jan 14
Prospectus supplement for primary offering
12:00am